Advances in the physiology of GPR55 in the central nervous system B A Marichal-Cancino, A Fajardo-Valdez, A E Ruiz-Contreras, ... Current Neuropharmacology 15 (5), 771-778, 2017 | 112 | 2017 |
Side effects associated with current and prospective antimigraine pharmacotherapies A González-Hernández, BA Marichal-Cancino, A MaassenVanDenBrink, ... Expert opinion on drug metabolism & toxicology 14 (1), 25-41, 2018 | 100 | 2018 |
Some prospective alternatives for treating pain: the endocannabinoid system and its putative receptors GPR18 and GPR55 R Guerrero-Alba, P Barragán-Iglesias, A González-Hernández, ... Frontiers in pharmacology 9, 1496, 2019 | 90 | 2019 |
Susceptibility for some infectious diseases in patients with diabetes: the key role of glycemia J Chávez-Reyes, CE Escárcega-González, E Chavira-Suárez, ... Frontiers in public health 9, 559595, 2021 | 82 | 2021 |
Potential metabolic and behavioural roles of the putative endocannabinoid receptors GPR18, GPR55 and GPR119 in feeding RE Ramírez-Orozco, R García-Ruiz, P Morales, CM Villalón, ... Current neuropharmacology 17 (10), 947-960, 2019 | 40 | 2019 |
Antimicrobial and antibiofilm activity of biopolymer-Ni, Zn nanoparticle biocomposites synthesized using R. mucilaginosa UANL-001L exopolysaccharide as a … JA Garza-Cervantes, CE Escárcega-González, ED Barriga Castro, ... International Journal of Nanomedicine, 2557-2571, 2019 | 39 | 2019 |
Possible role of hippocampal GPR55 in spatial learning and memory in rats B Marichal‑Cancino, A Fajardo‑Valdez, A Ruiz‑Contreras, ... Acta Neurobiologiae Experimentalis 78 (1), 41-50, 2018 | 36 | 2018 |
Blockade of GPR55 in the dorsolateral striatum impairs performance of rats in a T-maze paradigm BA Marichal-Cancino, A Sánchez-Fuentes, M Méndez-Díaz, ... Behavioural pharmacology 27 (4), 393-396, 2016 | 36 | 2016 |
Analysis of anandamide-and lysophosphatidylinositol-induced inhibition of the vasopressor responses produced by sympathetic stimulation or noradrenaline in pithed rats BA Marichal-Cancino, G Manrique-Maldonado, AH Altamirano-Espinoza, ... European journal of pharmacology 721 (1-3), 168-177, 2013 | 30 | 2013 |
Heteroreceptors modulating CGRP release at neurovascular junction: potential therapeutic implications on some vascular-related diseases A González-Hernández, BA Marichal-Cancino, J Lozano-Cuenca, ... BioMed Research International 2016, 2016 | 29 | 2016 |
Olcegepant blocks neurogenic and non‐neurogenic CGRPergic vasodepressor responses and facilitates noradrenergic vasopressor responses in pithed rats VH Avilés‐Rosas, E Rivera‐Mancilla, BA Marichal‐Cancino, ... British Journal of Pharmacology 174 (13), 2001-2014, 2017 | 25 | 2017 |
mGluR1/5 activation in the lateral hypothalamus increases food intake via the endocannabinoid system A Sánchez-Fuentes, BA Marichal-Cancino, M Méndez-Díaz, ... Neuroscience Letters 631, 104-108, 2016 | 21 | 2016 |
Potential mechanisms involved in palmitoylethanolamide-induced vasodepressor effects in rats BA Marichal-Cancino, A González-Hernández, A MaassenVanDenBrink, ... Journal of Vascular Research 57 (3), 152-163, 2020 | 18 | 2020 |
β-adrenoceptor blockade for infantile hemangioma therapy: Do β3-adrenoceptors play a role? CE Escarcega González, A González Hernández, CM Villalón, ... Journal of Vascular Research 55 (3), 159-168, 2018 | 18 | 2018 |
The periaqueductal gray and its extended participation in drug addiction phenomena P Vázquez-León, A Miranda-Páez, J Chávez-Reyes, G Allende, ... Neuroscience Bulletin 37, 1493-1509, 2021 | 17 | 2021 |
The oncogenic lysophosphatidylinositol (LPI)/GPR55 signaling A Calvillo-Robledo, RD Cervantes-Villagrana, P Morales, ... Life sciences 301, 120596, 2022 | 16 | 2022 |
NPY-Y1 receptors in dorsal periaqueductal gray modulate anxiety, alcohol intake, and relapse in Wistar rats P Vázquez-León, E Ramírez-San Juan, BA Marichal-Cancino, ... Pharmacology Biochemistry and Behavior 199, 173071, 2020 | 16 | 2020 |
Advances in neurobiology and pharmacology of GPR12 G Allende, J Chávez-Reyes, R Guerrero-Alba, P Vázquez-León, ... Frontiers in Pharmacology 11, 528446, 2020 | 16 | 2020 |
Dihydroergotamine inhibits the vasodepressor sensory CGRPergic outflow by prejunctional activation of α 2 - adrenoceptors and 5-HT 1 receptors AMCMV Abimael González-Hernández, Jair Lozano-Cuenca, Bruno A. Marichal-Cancino The Journal of Headache and Pain 19 (40), 2018 | 13 | 2018 |
Intrathecal dihydroergotamine inhibits capsaicin-induced vasodilatation in the canine external carotid circulation via GR127935-and rauwolscine-sensitive receptors BA Marichal-Cancino, A González-Hernández, G Manrique-Maldonado, ... European journal of pharmacology 692 (1-3), 69-77, 2012 | 13 | 2012 |